Discover one of our 28 local entrepreneurial communities »
Be the first to know as we launch in new countries and markets around the globe.
Interested in bringing MIT Technology Review to your local market?
Unsupported browser: Your browser does not meet modern web standards. See how it scores »
Several gene therapies are or will soon be in late-stage human trials. One of them could be the first to get FDA approval for sale in the U.S.
Are we prepared to know the genetic flaws of the unborn?
In 2012, genomics tiptoed into the doctor’s office, gene therapy rose again, and man and machine united.
A Boston startup wants to create precise genome-editing treatments that can address more types of disease than previous gene therapy methods.
From millions of random mutations, scientists identify a virus that could make gene therapy for inherited retinal diseases safer and more effective.
New partnerships could help bring a novel class of biopharmaceutical to patients.
Patients can turn off an experimental treatment if side effects get too bad.
Regulatory approval of a gene therapy treatment in Europe could spark broader patient access to the technology.
An upcoming clinical trial will attempt to solve problems that have plagued one potentially promising treatment.
Author of The Eighth Day of Creation and a Technology Review contributor dies.